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Background: The genetic diversity of Plasmodium falciparum has been extensively studied in various parts of the
world. However, limited data are available from Mauritania. The present study examined and compared the genetic
diversity of P. falciparum isolates in Mauritania.
Methods: Plasmodium falciparum isolates blood samples were collected from 113 patients attending health
facilities in Nouakchott and Hodh El Gharbi regions. K1, Mad20 and RO33 allelic family of msp-1 gene were
determined by nested PCR amplification.
Results: K1 family was the predominant allelic type carried alone or in association with Ro33 and Mad20 types
(90%; 102/113). Out of the 113 P. falciparum samples, 93(82.3%) harboured more than one parasite genotype. The
overall multiplicity of infection was 3.2 genotypes per infection. There was no significant correlation between
multiplicity of infection and age of patients. A significant increase of multiplicity of infection was correlated with
parasite densities.
Conclusions: The polymorphism of P. falciparum populations from Mauritania was high. Infection with multiple
P. falciparum clones was observed, as well as a high multiplicity of infection reflecting both the high endemicity
level and malaria transmission in Mauritania.
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Malaria remains a public health problem in Mauritania
with an estimated of 250,000 clinical cases reported an-
nually [1]. Data reported during the two last decades
shown an increase in malaria cases from 26.933 in 1990
to 188.025 in 2006 [2]. The majority of infection is due
to Plasmodium falciparum, which is responsible for more
than 80% of malaria cases and entomological studies
show that the main vector is Anopheles gambiae [1,3-7].
Throughout the country malaria is endemic with a sea-
sonal transmission from July to October, as is the case* Correspondence: alimedsalem@gmail.com
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distribution, and reproduction in any mediumin the most Sahelian countries [1,8]. The country can be
divided into three epidemiological strata: the Saharan
region in the north, representing 80% of the country’s
area with annual rainfall less than 100 mm, where mal-
aria transmission is rare. A sero-epidemiological study
conducted in 1980s showed prevalence between 8 and
15% of history of infection with P. falciparum in this
zone [9]. In the Sahelian zone, located in the southern
part, between Nouakchott and Nema (annual rainfall
100-300 mm), malaria is unstable and seasonal trans-
mission during rainy season can cause deadly epidemics
[3,4]. The Sudanian region in the South, bordering with
the Senegal River Valley (annual rainfall 300-600 mm),
an agricultural area, including rice, where malaria trans-
mission is stable, but with a significant difference in
prevalence between the rainy season and the dry seasond Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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toward malaria control and prevention [10], multiple fac-
tors including insecticide resistance in anopheline vectors,
the lack of effective vaccines, and the emergence and rapid
spread of drug-resistant strains are the major problems for
controlling and preventing malaria.
Therefore, the development of an effective malaria vac-
cine continues to be urgently needed. However, extensive
genetic diversity in natural malaria parasite populations
is a major obstacle for the development of an effective
vaccine against these parasites, because antigenic diversity
limits the efficiency of acquired protective immunity to
malaria [11,12]. Many P. falciparum proteins have been
proposed for use as vaccine candidate antigens, but the
merozoite surface protein-1 (MSP-1) has been most
studied [13,14]. Extensive genetic polymorphism of the
msp-1 gene has been identified in P. falciparum isolates
worldwide [15-17]. It is important to investigate the
diversity of msp-1 gene, in different geographic areas for
the further development of effective malaria vaccine. The
gene coding the merozoite surface protein 1 (msp-1) has
been widely used as a marker for genotyping parasite
populations [18-20]. In P. falciparum, the surface protein
MSP-1 (around 190 kDa) plays an important role in
erythrocyte invasion by the merozoite [21]. The protein
is a principal target of human immune responses [22]
and is a promising candidate for a blood stage subunit
vaccine [14,23]. The msp-1 gene occurs as one of three
distinct allelic families: K1, MAD20 and Ro33 [24]. It
has 7 variable blocks that are separated either by con-
served or semi-conserved regions. Block 2, a region nearFigure 1 Map of Mauritania showing the study sites.the N-terminal of MSP-1, is the most polymorphic part
of the antigen and appears to be under the strongest
diversifying selection within natural populations [21].
The genetic diversity of P. falciparum has been exten-
sively studied in various parts of the world, but limited
data are available from Mauritania. The only study on
P. falciparum population genetic structure using msp-1,
msp-2 and glurp markers date back 15 years [4]. The
present study examined and compared the genetic di-
versity of P. falciparum isolates among febrile patients
attending health facilities in Nouakchott and Hodh El
Gharbi region in Mauritania, during the peak of malaria
transmission, using the polymorphic gene encoding for
the merozoite surface protein-1 (MSP-1).
Methods
Study sites
The study was conducted in Hodh El Gharbi (HG),
south-east Mauritania, and in Nouakchott, the capital
city of Mauritania during the rainy season in September–
October 2010 (Figure 1). HG region (latitude 16° 13′
02″ N, longitude 9° 54′ 44″ W) covers a surface area of
53,000 km2 with four departments, (Aïon, Kobeni, Tintane
and Tamchekett). The population of HG is approximately
212,156 inhabitants [25]. Most residents are subsistence
animal breeders and farmers. The climate in HG region is
Sahelian characterized by a long dry season, lasting from
October to June, and a rainy season extending from July
to September. It receives between 200-300 mm of annual
rainfall. The monthly mean temperature ranges from 24
to 37°C. A transmauritanian highway of 1,200 km from
Table 1 Sequences of oligonucleotide primers used to
genotype msp-1 block 2 allelic types of Plasmodium








K1F 5′AAGAAATTACTACAAAAGGTG3′ K1 family
specific
K1R 5′TGCATCAGCTGGAGGGCTTGCACCAC3′ K1 family
specific
Ro33F 5′AGGATTTGCAGCACCTGGAGATCT3′ Ro33 family
specific
Ro33R 5′GAGCAAATACTCAAGTTGTTGCA3′ Ro33 family
specific
Mad20F 5′TGAATTATCTGAAGGATTTGTACGTC3′ Mad20 family
specific
Mad20R 5′GAACAAGTCGAACAGCTGTTA3′ Mad20 family
specific
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the country passes through HG from west to east. HG
region can also be reached on a paved road from Nioro du
Sahel in Mali. The region is poorly served by health ser-
vice facilities. There is only one hospital in Aïoun and one
health centre in each department. Nouakchott (18°.11′N;
16°.16′W), is situated in a Saharan zone, near the Atlantic
coast at an average altitude of 7 m. It comprises nine
districts and houses 743,511 inhabitants corresponding to
one fourth of the whole population of the country [25]. The
wet season is short, extending from July to September, with
little annual variation in the amount of rainfall (50-80 mm).
The monthly mean temperatures in Nouakchott varied
from 21°C to 30.5°C. Nouakchott is served by five hospi-
tals and nine health centres spread across the city. HG
and Nouakchott exhibit every year high level of human
migration with Nouakchott residents traveling and staying
in Hodh El Gharbi during the months of July, August,
September corresponding to the school vacations, and
returning to Nouakchott in October and November.
Patients and blood samples collection
The samples of this study were collected from 676 febrile
patients attending Kobeni, Tintane and Aïoun health facil-
tities in HG region and the ‘Centre Hospitalier National’,
‘Centre Hospitalier Cheikh Zayed’ and ‘Centre de Santé de
Teyarett’ in Nouakchott. Before blood sample collection,
informed consent was obtained from all participants or
in case of children from their parents/legal guardians
prior to their enrolment. The study was approved by
‘the Direction Régionale de l’Action Sanitaire, DRAS, under
the authority of the Mauritanian Ministry of Health.
During the study, if patient presented to health facilities
with symptoms consistent with mild malaria, including
fever, chills, headache, and a positive slide, they were of-
fered standard ACT as first-line treatment. Among the pa-
tients enrolled, 276 (40.8%) were microscopically confirmed
as P. falciparum infection. Out of these 114 (40.7%) pa-
tients were from Kobeni, 89(31.7%) from Tintane and
55(19.6%) from Aïoun in HG region and 18(6.5%) pa-
tients from Nouakchott. A total of 113 patients were
randomly selected from the 276 P. falciparum positives
patients by microscopy. A finger prick blood sample
was taken from each consenting patient for thick and
thin blood film and 2-3 drops were collected on What-
man® No. 3 filter paper, dried and stored in individual
plastic bag until used for DNA extraction.
Malaria parasite identification
Thick and thin smears were stained with Giemsa. Parasite
density was determined by counting the number of
asexual parasites per 200 white blood cells, and calcu-
lated per microlitre using the following formula: num-
ber of parasites x 8,000/200, assuming a white bloodcell count of 8,000 cells per μl [26]. Absence of malaria
parasites in 200 high power ocular fields of the thick
film was considered as negative. Obtained data were
graded according to parasitaemia: 1, patients with 50-499
parasites/μl; 2, patients with 500-4,999 parasites/μl; 3,
patients with more than 5,000 parasites/μl.
Plasmodium falciparum DNA extraction
Parasite DNA was extracted, from blood samples blotted
on filter paper by methanol method described by Djimde
et al. [27]. Briefly, 500 μl of methanol was added to a
1.5 ml microcentrifuge tube containing three or four
pieces of filter paper and incubated at 15 min at room
temperature. The methanol was poured off and the papers
heated at 95-100°C in 50-70 μl of sterile distilled water
for 15 minutes of incubation, during which the tube was
gently vortexed every five minutes. The samples were
centrifuged twice and the final supernatant was stored
at −20°C until used for the amplification reaction. All PCR
analyses were conducted in the ‘Service de Parasitologie’
at the Faculty of Medicine, Université Cheikh Anta Diop,
Dakar.
PCR amplification of the P. falciparum msp-1 gene
The highly polymorphic locus, msp-1 block 2, was used
for the genotyping of the P. falciparum population using
the nested polymerase chain reactions (PCR) technique.
The msp −1 primers sequences used in this study are
shown in Table 1 [28]. For the primary amplifications
(outer PCR), primer pairs corresponding to the flanking
sequence of the conserved regions of msp −1 was used
(Table 1). The second amplification reactions (nested
Table 2 Population characteristics of P. falciparum
infected patients from different study sites in Mauritania
Characteristics Kobeni Tintane Aïoun Nouakchott Total
n (%) n (%) n (%) n (%) n (%)
Gender
Male 20(55.6) 27(69.2) 12(6) 11(61.1) 70(61.9)
Female 16(44.4) 12(30.8) 8(4) 7(38.9) 43(38.1)
Age group
< 5 1(2.8) 1(2.56) 2(10.0) 0 4(3.5)
5-19 21(58.3) 23(59.0) 13(65.0) 6(33.3) 63(55.8)
20-39 13(36.1) 7(17.95) 4(20.0) 8(44.5) 32(28.3)
≥ 40 1(2.8) 8(20.5) 1(5.0) 4(22.2) 14(12.4)
Total 36(31.8) 39(34.5) 20(17.7) 18(16.0) 113(100)
n: number of individuals.
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specific primers sets corresponding to K1, RO33 and
Mad20 families of msp-1. The primers for msp −1 used
in this study are shown in Table 1. All outer and nested
PCR reactions were done in 25 μl final volume. For each
reaction, 200 μM each of deoxyribonucleoside triphos-
phate (dNTP), 1 μM of each primer, 0.5U of Taq DNA
polymerase and PCR Buffer 10X containing 100 mM
Tris–HCl, pH 8.3, 500 mM KCl, 15 mM MgCl2 and
0.01% gelatin were used. The outer and the nested amp-
lification were performed on an Applied Biosystem 2720
and PTC-100 Peltier Thermal Cycler respectively using
the following conditions: initial denaturation for 3 min
at 94°C, followed by 30 cycles of 25 s denaturation at
94°C, 35 s annealing at 50°C, and 2 min 30 extension at
68°C. Final extension was carried out at 72°C for 3 min.
Nested PCR products were visualized by electrophoresis
on 2% agarose gel (Gibco-BRL) for various lengths of time
depending of the predicted size of the PCR products and
visualized under UV trans-illumination.Allelic distribution and multiplicity of infection
The msp-1 alleles were categorized by their molecular
weights and considered the same if their molecular weights
were approximately within 10 bp [29]. The multiplicity of
infection (MOI), or complexity of infection, was estimated
by the average number of PCR fragments per infected
individual, as described by Zwetyenga et al. [30].Statistical analyses
Statistical analyses were performed using MedCalc for
Windows, version 12.3.0.0 (MedCalc Software, Mariakerke,
Belgium). Proportions were compared for significance
using the χ2-test. Spearman’s rank correlation coeffi-
cients were calculated to assess associations between
multiplicity of infection, parasite densities and age groups
of patients under study. A P value of ≤ 0.05 was considered
indicative of a statistically significant difference.Results
Characteristics of the study population
Out of the 113 randomly selected P. falciparum patients
attending health facilities in study sites, 31.8% (36/113)
were from Kobeni, 34.5% (39/113) from Tintane, 17.7%
(20/113) from Aïoun and 16% (18/113) from Nouakchott
(Table 2). Males (70/113; 61.9%) were significantly
higher (χ2 = 6.4; p = 0.01) than females (43/113; 38.1%).
Patients belonging to the age group 5-19 years were the
most represented with 55.8% (63/113) followed by those
of 20-39 years of ages with 28.3% (32/113), patients
whose ages ≥ 40 years with 12.4% (14/113) and children
under five years representing 3.5% (4/113).Allelic polymorphism of msp-1
Allele typing revealed highly polymorphic nature of
Mauritanian P. falciparum isolates with respect to msp-1
gene. K1, Mad20 and Ro33 MSP1 allele’s types were
identified. The total number of different sized alleles de-
tected in this sample was 27. Among them, nine for K1
(160-400 bp), 12 for Mad20 (140-400 bp) and six for
Ro33 (160-360 bp) allele families were noted. Frequen-
cies of different msp-1 alleles and their combinations
and multiplicity of infection are shown in Table 3. The
frequency of samples with only K1, Mad20 and Ro33
were 10.6% (12/113), 2.6% (3/113) and 4,4% (5/113) re-
spectively. K1/Mad20, K1/Ro33 and Mad20/Ro33 com-
binations were found in 21.2% (24/113), 16.8% (19/113)
and 2.6% (3/113) of samples respectively and 41.6% (47/
113) of them harbored all three allelic types. Prevalence
of K1, Mad20 and Ro33 allelic types was 90.0% (102/113),
68.1% (76/113) and 65.5% (74/252) respectively. Multiple
clones infections over all study sites was 82.3% (93/113)
with a minimum of 72.2% (13/18) in Nouakchott and a
maximum of 90.0% (18/20) in Aïoun. Multiplicity of infec-
tion (MOI) was highest in P. falciparum infected patients
enrolled in Aïoun health facility (4.3 genotypes per infec-
tion) and lowest in those from Nouakchott health facilities
(2.3; mean of three health facilities). However, obtained
MOI values were not statistically different from each other
(p = 0.56). The estimated MOI of all studied area was 3.2
genotypes per infection.
Relationship between multiplicity of infection, age groups
and parasite densities
Age group distribution of P. falciparum-infected patients
and msp-1 block 2 allelic types is shown in Table 4. The
prevalence of K1, Mad20, Ro33 and their different combi-
nations was significantly higher among patient aged 5-
19 years compared to other age groups (p < 0.05) (Table 4).
However, no significant correlation between multiplicity
Table 3 Msp-1 block 2 allelic type frequencies and multiplicity of infection of P. falciparum isolates from different
study sites in Mauritania
Allelic type Kobeni Tintane Aïoun Nouakchott Total
n (%) n (%) n (%) n (%) n (%)
K1 4(11.1) 6(15.4) 1(5.0) 1(5.5) 12(10.6)
Mad20 1(2.8) 0 1(5.0) 1(5.5) 3(2.6)
Ro33 0 2(5.1) 0 3(16.7) 5(4.4)
K1/Mad20 7(19.4) 10(25.6) 6(30.0) 1(5.5) 24(21.2)
K1/Ro33 9(25.0) 4(10.2) 0 6(32.3) 19(16.8)
Mad20/Ro33 2(5.5) 0 0 1(5.5) 3(2.6)
K1/Mad20/Ro33 13(36.1) 17(43.6) 12(60.0) 5(27.8) 47(41.6)
Total 36(100.0) 39(100.0) 20(100.0) 18(100.0) 113(100.0)
Total K1 33(91.6) 37(94.9) 19(90.0) 13(72.2) 102(90.0)
Total Mad20 23(63.8) 27(69.2) 19(90.0) 7(38.8) 77(68.1)
Total Ro33 24(66.6) 23(58.9) 12(60.0) 15(83.3) 74(65.5)
Multiclonal isolates 31(86.1) 31(79.5) 18(90.0) 13(72.2) 93(82.3)
MOI 3.1 3.2 4.3 2.3 3.2
n: number of individuals; MOI: multiplicity of infection.
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rank coefficient = 0.2; p = 0.8) was noted. The distribu-
tion of K1, Mad20 and Ro33 according to parasitaemia
is shown in Table 5. This study found that the individ-
ual distribution of K1, Mad20, Ro33 was not signifi-
cantly different among parasitaemic groups (p = 0.94).
Multiclonal isolates was not significantly different nei-
ther between 50-499 parasites/μl and ≥ 5000 parasites/μl
(p = 0.09), or between 50-499 parasites/μl and 500-4999
parasites/μl (p = 0.08). However, estimated parasitaemiaTable 4 Distribution of P. falciparum msp-1 block 2 allelic
type among age groups of P. falciparum infected patients
from Mauritania
Age group (years)
Allelic type < 5 5-19 20-39 ≥40 Total
n (%) n (%) n (%) n (%) n (%)
K1 1(0.9) 8(7.1) 1(0.9) 2(1.8) 12(10.6)
Mad20 0 1(0.9) 2(1.8) 0 3(2.6)
Ro33 0 2(1.8) 2(1.8) 1(0.9) 5(4.4)
K1/Mad20 1(0.9) 17(15.0) 6(5.3) 0 24(23.0)
K1/Ro33 1(0.9) 10(8.8) 6(5.3) 2(1.8) 19(16.8)
Mad20/Ro33 0 2(1.8) 1(0.9) 0 3(2.6)
K1/Mad20/Ro33 1(0.9) 23(20.3) 14(12.4) 9(7.9) 47(41.6)
Total 4(3.5) 63(55.7) 32(28.4) 14(12.4) 113(100.0)
Total K1 4(100.0) 58(92.1) 27(84.3) 13(92.8) 102(90.3)
Total Mad20 2(50.0) 43(68.2) 23(71.8) 9(64.3) 77(68.1)
Total Ro33 2(50.0) 37(58.7) 23(71.8) 12(85.7) 74(65.5)
Multiclonal isolates 3(2.6) 52(46.0) 27(23.9) 11(9.7) 93(82.3)
MOI 3.25 3.21 3.03 3.37 3.2
n: number of individuals; MOI: multiplicity of infection.and multiplicity of P. falciparum infection was signifi-
cantly correlated (Spearman rank coefficient = 1; p < 0.01).
Discussion
This study was undertaken to assess the polymorphism
of the merozoite surface protein-1 block 2 allelic types
in P. falciparum isolates from different study sites in
Mauritania. Plasmodium falciparum is thought to be
responsible of nearly 80% of diagnosed malaria cases in
the country [1]. A better understanding of population
structure of P. falciparum genotypes may be an important
element for implementing malaria control strategies in the
country. Data showed a relatively high polymorphic nature
of K1, Mad20 and Ro33 msp-1 allelic types according to
the number of band sizes (27 different PCR products: 9 K1,
12 Mad20 and 6 Ro33) among Mauritanian P. falciparum
isolates. Comparable results were found by Jordan et al.
[4]; authors noted 11, 8 and 2 different sized alleles re-
spectively for K1, Mad20 and Ro33 in P. faliparum isolates
from malaria patients in Aïoun and Kobeni area located in
southern Mauritania. The number of different msp-1
alleles observed among P. falciparum isolates is also
comparable to that founded by Konate et al. [31] in the
holoendemic area of Dielmo (Senegal) where 33 msp-1
alleles were evidenced, but less than that reported by
Soulama et al. [29] who founded 41 different sized al-
leles for msp-1 block 2 region in P. falciparum isolates
collected from children with uncomplicated malaria
infection living in Burkina Faso. The study also re-
vealed the predominance of K1 type alleles either at
study site level or throughout the parasite population
compared to Mad20 and Ro33. Similar finding have
previously reported among P. falciparum isolates from
Table 5 Distribution of Msp-1 block 2 allelic types among parasitaemic groups of P. falciparum infected patients from
Mauritania
Allelic type Parasitaemia*
50-499 n (%) 500-4999 n (%) ≥5000 n (%) Total
K1 1(0.9) 6(5.3) 5(4.4) 12(10.6)
Mad20 1(0.9) 2(1.8) 0 3(3.5)
Ro33 0 2(1.8) 3(2.6) 5(4.4)
K1/Mad20 1(0.9) 10(8.8) 13(11.5) 24(21.2)
K1/Ro33 6(5.3) 9(7.9) 4(3.5) 19(16.8)
Mad20/Ro33 0 1(0.9) 2(1.8) 3(2.6)
K1/Mad20/Ro33 2(1.8) 22(19.5) 23(20.3) 47(41.6)
Total 11(9.7) 52(46.0) 50(44.3) 113(100.0)
Total K1 10(90.9) 47(90.4) 45(90.0) 102(90.3)
Total Mad20 4(36.4) 35(67.3) 38(76.0) 77(68.1)
Total Ro33 8(72.7) 34(65.4) 42(84.0) 74(65.5)
Multiclonal isolates 9(7.9) 42(37.2) 42(37.2) 93(82.3)
MOI 2.6 3.4 3.6 3.2
(*) parasite/μl of blood; n: number of individuals; MOI: multiplicity of infection.
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from 48 Senegalese patients hospitalized for malaria
showed a prevalence of 68% for K1 alleles [32]. Most of
the isolates were mixed infections (82.3%) which har-
bored more than one allele type. However, prevalence
of patients with multiclonal infection was similar in all
study sites. A relatively high multiplicity of infections
(MOI) was observed among P. falciparum patients ei-
ther at study site level (2.33-4.25) or over all the study
sites (3.22) reflecting the high intensity level of malaria
transmission during the study period. When they com-
pared 63 P. falciparum positve samples taken from fe-
brile patients in Aïoun and 110 positive samples from
Kobeni, Jordan et al. [4] reported a multiple infections
of 1.57 and 2.34, respectively. It is reported that the
multiplicity of infection in an infected patient may be
due to an important entomological inoculation rate as
shown in the Senegal village of Dielmo where patients
receive a large number of infective bites [31], or by a
single mosquito carrying several parasitic clones in his
inoculums [33]. In the context of the present study, it
is difficult to speculate on the influence of mosquito
inoculum on the multiplicity of infection because no
such data is available for the study sites in Mauritania.
The MOI values reported in this study are consistent
with those reported from regions with high malaria en-
demicities [34]. Furthermore, there was no association
between MOI and age of patients. Investigations con-
ducted in Senegal (Ndiop village where malaria is mesoen-
demic and seasonal) and Benin (Cotonou), founded that
MOI was not affected by age of malaria patients [31,35].
Previous studies regarding the variation of MOI over agehave suggested that the influence of age on the multiplicity
of infection is highly affected by endemicity of malaria
which is probably a reflection of the development of
anti-parasite specific immunity [36]. However, this finding
contrasting with reports from other locations [29,31,37]. A
positive correlation between multiplicity of infection and
parasite densities was observed in this study (MOI = 2.6-
3.6). This is consistent with many reports demonstrating
that higher parasite densities increase the probability of
detecting concurrent clones in an individual [18,38]. This
study used P. falciparum isolates from patients with clin-
ical symptoms, so that the MOI may be lower than that
reported in asymptomatic patients [39]. Many reports
showed that MOI would reflect that infected individual
has immunity against malaria [31]. Thus, the MOI should
be studied in asymptomatic P. falciparum-infected popu-
lation in Mauritania further, particularly in children. The
similarity between P. falciparum strains could be ex-
plained by population migration between study sites that
may allow for exchanges of parasite population. Similar re-
sults were noted in many malaria endemic areas [40-42].
The present study is the second report based on molecular
epidemiology of P. falciparum following the work con-
ducted by Jordan et al. [4] in Aïoun and Kobeni Depart-
ment of HG region and the first with respect to Tintane
department in the same region and Nouakchott, the cap-
ital city of Mauritania. It demonstrates that P. falciparum
populations, at leat in Kobeni and Aïon, had maintained
a high level of polymorphism in the msp-1 block 2 re-
gion. Studies using a larger number of blood samples
collected from different geographic areas in Mauritania
are required not only to determine the nationwide
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but also to implement malarial control programmes in this
neglected malaria country.
Conclusions
Plasmodium falciparum isolates from Mauritania exhib-
ited a high degree of genetic polymorphism in msp-1 gene
and most of the infected patients carried multiple clones
of parasites reflecting the high level of malaria endemicity
in study sites during malaria transmission season.
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